51 participants
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-30
- Start Date:
- 2020-11-18
- Completion:
- 2025-12-23
Conditions
- Solid Tumor
- Advanced Cancer
- Metastatic Cancer
Interventions
- DRUG
No Results Yet